-
Partners and Donors Alzheimer Society of Canada
https://braincanada.ca/fr/subventions-financées/partners-and-donors-alzheimer-society-of-canadaPartners and Donors Alzheimer Society of Canada Alzheimer’s disease is a common form of memory loss and confusion affecting older adults. Despite many years of study, we still don’t have a cure for this disease. Project Overview Alzheimer’s disease is a common form of memory loss and confusion...
-
Pathogenic Mechanism of C9orf72 haploinsufficiency in ALS/FTLD: a road to therapeutic discovery
https://braincanada.ca/fr/subventions-financées/pathogenic-mechanism-of-c9orf72-haploinsufficiency-in-als-ftld-a-road-to-therapeutic-discoveryIn this Hudson project, the team led by Dr. Robertson will pursue a comprehensive understanding of the normal functions of C9ORF72 and provide a better determination of whether loss of these functions via mutation may cause or contribute to ALS. Project Overview In this Hudson project, the team led...
-
Pathogenic mechanisms of C9ORF72 repeat expansion in ALS and development of therapeutics
https://braincanada.ca/fr/subventions-financées/pathogenic-mechanisms-of-c9orf72-repeat-expansion-in-als-and-development-of-therapeuticsDr. Patten started his research career as a PhD student at the University of Alberta under the supervision of Dr. Declan Ali in 2004. Project Overview Dr. Patten started his research career as a PhD student at the University of Alberta under the supervision of Dr. Declan Ali in 2004. There he...
-
Patient-reported outcome measures for social robots in dementia care
https://braincanada.ca/fr/subventions-financées/patient-reported-outcome-measures-for-social-robots-in-dementia-careImproving independence and quality of life for persons living with dementia (PLWD) and their care partners can be realized by complementing human care with robotic assistive technologies. Project Overview Improving independence and quality of life for persons living with dementia (PLWD) and their...
-
Penser différemment : l'autisme dans les communautés des Premières nations
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/penser-différemment-l-autisme-dans-les-communautés-des-premières-nationsBruno Grant, lauréat du prix d'excellence Shireen et Edna Marcus de Brain Canada, s'efforce de mieux comprendre l'autisme dans les communautés des Premières nations de Maskwacis. Située dans le centre de l'Alberta, la communauté crie des plaines de Maskwacis définit les troubles du spectre...
-
Percer les mystères de la maladie d'Alzheimer : Prix de la recherche sur la maladie d'Alzheimer de la Colombie-Britannique
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/percer-les-mystères-de-la-maladie-d-alzheimer-prix-de-la-recherche-sur-la-maladie-d-alzheimer-du-bcPercer les mystères de l'Alzheimer : BC Alzheimer's Research Award, un partenariat de 7,5 millions de dollars entre Brain Canada, la Michael Smith Foundation for Health Research (MSFHR), Genome BC et la Pacific Alzheimer Research Foundation (PARF). Vidéo non disponible.
-
Personalized medicine for Bipolar disorder: clinical lithium response as a guide to mode of action and biomarker discovery using human neurons and biofluids
https://braincanada.ca/fr/subventions-financées/personalized-medicine-for-bipolar-disorder-clinical-lithium-response-as-a-guide-to-mode-of-action-and-biomarker-discovery-using-human-neurons-and-biofluidsBipolar Disorder (BD) is a chronic psychiatric illness, ranking in the top 10 causes of disability and mortality worldwide, due to suicide and cardiovascular death. Project Overview Bipolar Disorder (BD) is a chronic psychiatric illness, ranking in the top 10 causes of disability and mortality...
-
PET imaging of Alzheimer’s-induced inflammation to monitor progression and therapy response using a novel fructose-based radiotracer
https://braincanada.ca/fr/subventions-financées/pet-imaging-of-alzheimer-s-induced-inflammation-to-monitor-progression-and-therapy-response-using-a-novel-fructose-based-radiotracerOne of the key processes driving Alzheimer’s Disease is inflammation in the brain, the severity of which may predict the severity of disease. Project Overview One of the key processes driving Alzheimer’s Disease is inflammation in the brain, the severity of which may predict the severity of...
-
Peut-on reprogrammer nos cellules existantes pour remplacer les neurones endommagés par la SLA? Ce stagiaire postdoctoral souhaite le découvrir
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/reprogrammer-des-cellules-pour-remplacer-les-neurones-endommagés-par-l-alsRencontrez les jeunes chercheurs à l'origine des bourses de stage SLA Canada - Cerveau Canada 2022. Le Dr Hussein Ghazale est le lauréat d'une bourse de formation SLA Canada - Cerveau Canada 2022 d'une valeur de 165 000 $. Rencontrez les jeunes chercheurs à l'origine des bourses de stage SLA Canada...
-
Phenotyping of Alzheimer’s disease across imaging-defined stages of cerebral amyloid angiopathy
https://braincanada.ca/fr/subventions-financées/phenotyping-of-alzheimer-s-disease-across-imaging-defined-stages-of-cerebral-amyloid-angiopathyMixed dementia is the most common form of dementia. Project Overview Background: Mixed dementia is the most common form of dementia. It occurs when Alzheimer’s disease (AD) combines with vascular disease, affecting both the blood vessels and the immune function in our brain. As this happens, memory...
Passer au contenu principal
